AR049934A1 - Nuevo uso de meloxicam en medicina veterinaria - Google Patents
Nuevo uso de meloxicam en medicina veterinariaInfo
- Publication number
- AR049934A1 AR049934A1 ARP050102566A ARP050102566A AR049934A1 AR 049934 A1 AR049934 A1 AR 049934A1 AR P050102566 A ARP050102566 A AR P050102566A AR P050102566 A ARP050102566 A AR P050102566A AR 049934 A1 AR049934 A1 AR 049934A1
- Authority
- AR
- Argentina
- Prior art keywords
- meloxicam
- treatment
- inflammatory
- mild
- cases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
Abstract
La presente se dirige al uso de una formulacion que contiene meloxicam o una sal de meloxicam farmacologicamente aceptable de una base orgánica o inorgánica y uno o más vehículos para preparar una composicion médica veterinaria con eficacia analgésica para el tratamiento de enfermedades dolorosas inflamatorias, particularmente para el tratamiento de casos de mastitis suave o moderada. El tratamiento conduce a una reduccion duradera eficaz de un estado hipersensible asociado con un dolor inflamatorio en casos de mastitis suave o moderada, particularmente en estados cronicos de la misma.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004030409A DE102004030409A1 (de) | 2004-06-23 | 2004-06-23 | Neue Verwendung von Meloxicam in der Veterinärmedizin |
Publications (1)
Publication Number | Publication Date |
---|---|
AR049934A1 true AR049934A1 (es) | 2006-09-13 |
Family
ID=34980206
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP050102566A Pending AR049934A1 (es) | 2004-06-23 | 2005-06-22 | Nuevo uso de meloxicam en medicina veterinaria |
Country Status (14)
Country | Link |
---|---|
US (1) | US20050288280A1 (es) |
EP (1) | EP1761269A1 (es) |
JP (1) | JP2008503509A (es) |
KR (1) | KR20070036146A (es) |
CN (1) | CN1972690A (es) |
AR (1) | AR049934A1 (es) |
AU (1) | AU2005256377B2 (es) |
BR (1) | BRPI0512311A (es) |
CA (1) | CA2570596A1 (es) |
DE (1) | DE102004030409A1 (es) |
MX (1) | MXPA06014599A (es) |
NZ (1) | NZ552718A (es) |
SG (1) | SG157402A1 (es) |
WO (1) | WO2006000306A1 (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020035107A1 (en) | 2000-06-20 | 2002-03-21 | Stefan Henke | Highly concentrated stable meloxicam solutions |
DE10161077A1 (de) * | 2001-12-12 | 2003-06-18 | Boehringer Ingelheim Vetmed | Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion |
US8992980B2 (en) * | 2002-10-25 | 2015-03-31 | Boehringer Ingelheim Vetmedica Gmbh | Water-soluble meloxicam granules |
US8512727B2 (en) | 2003-03-03 | 2013-08-20 | Alkermes Pharma Ireland Limited | Nanoparticulate meloxicam formulations |
US20100297252A1 (en) | 2003-03-03 | 2010-11-25 | Elan Pharma International Ltd. | Nanoparticulate meloxicam formulations |
EP1568369A1 (en) * | 2004-02-23 | 2005-08-31 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the treatment of respiratory diseases in pigs |
DE102004021281A1 (de) * | 2004-04-29 | 2005-11-24 | Boehringer Ingelheim Vetmedica Gmbh | Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin |
BRPI0617208A2 (pt) * | 2005-09-30 | 2011-07-19 | Boehringer Ingelheim Vetmed | preparação farmacêutica contendo meloxicam |
CA2649895C (en) * | 2006-04-19 | 2013-03-26 | Novadel Pharma Inc. | Stable hydroalcoholic oral spray formulations and methods |
US8999395B2 (en) * | 2007-02-09 | 2015-04-07 | Ceva Sante Animale | Pharmaceutical compositions for oral administration in the form of stabilised aqueous suspensions |
AU2009264307A1 (en) * | 2008-06-24 | 2009-12-30 | Intervet International B.V. | Pharmaceutical transdermal compositions and method for treating inflammation in cattle |
TR200809200A1 (tr) | 2008-12-01 | 2009-12-21 | Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket� | Meloksikam içeren farmasötik formülasyonlar |
CA2763456C (en) | 2009-05-27 | 2017-10-24 | Alkermes Pharma Ireland Limited | Reduction of flake-like aggregation in nanoparticulate active agent compositions |
WO2011046853A1 (en) | 2009-10-12 | 2011-04-21 | Boehringer Ingelheim Vetmedica Gmbh | Containers for compositions comprising meloxicam |
EP2512504A4 (en) * | 2009-12-15 | 2013-06-19 | Dec Int Nz Ltd | COMPOSITION AND THERAPEUTIC METHOD |
US9149480B2 (en) | 2010-03-03 | 2015-10-06 | Boehringer Ingeleheim Vetmedica GmbH | Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats |
US9795568B2 (en) | 2010-05-05 | 2017-10-24 | Boehringer Ingelheim Vetmedica Gmbh | Low concentration meloxicam tablets |
US20130190252A1 (en) * | 2010-05-18 | 2013-07-25 | Pharmathen S.A. | Pharmaceutical formulation containing lipophilic drugs and milk as a solubilizing/dispensing agent and method for the preparation thereof |
WO2012009542A2 (en) * | 2010-07-14 | 2012-01-19 | Kansas State University Research Foundation | Methods for alleviating chronic pain and improving performance of cattle undergoing dehorning or castration |
CN103690480A (zh) * | 2013-12-18 | 2014-04-02 | 吉林修正药业新药开发有限公司 | 治疗类风湿性关节炎、骨性关节炎的美洛昔康注射液及其制备方法 |
CN104983686A (zh) * | 2015-07-13 | 2015-10-21 | 胡涵 | 畜禽用美洛昔康可溶性粉剂及其制备方法 |
KR20200130334A (ko) * | 2018-03-08 | 2020-11-18 | 바우닥스 바이오, 인코포레이티드 | 멜록시캄의 일시 투여량을 정맥내 투여하는 방법 |
US11040008B2 (en) * | 2018-04-04 | 2021-06-22 | Slayback Pharma Llc | Pharmaceutical compositions of meloxicam |
US20220105029A1 (en) * | 2020-10-07 | 2022-04-07 | The Board Of Trustees Of The University Of Arkansas | Biodegradable chitosan microneedle patch for transdermal delivery for livestock pain management |
WO2022251876A1 (en) * | 2021-05-28 | 2022-12-01 | Veterinary Pharmacy Corporation | Water soluble complex compositions and methods thereof |
Family Cites Families (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2795529A (en) * | 1954-06-17 | 1957-06-11 | American Home Prod | Stabilized hyaluronidase solution containing calcium chloride |
US3288675A (en) * | 1964-03-20 | 1966-11-29 | Hoffmann La Roche | Parenteral sulfonamide compositions and processes |
BE789726A (fr) * | 1971-10-06 | 1973-04-05 | Merck & Co Inc | Suppositoires a l'indomethacine |
DE2756113A1 (de) * | 1977-12-16 | 1979-06-21 | Thomae Gmbh Dr K | Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel |
DE3217315C2 (de) * | 1982-05-08 | 1986-05-22 | Gödecke AG, 1000 Berlin | Arzneimittelzubereitungen mit einem Gehalt an Oxicam-Derivaten |
US4543200A (en) * | 1983-09-28 | 1985-09-24 | Sherman Laboratories, Inc. | Contact lens preservative system cleaner and method |
HU195918B (en) * | 1984-03-14 | 1988-08-29 | Jerome Corbiere | Process for producing pharmaceutical compositions containing non-steroide antiflogistic active components |
DE3437232A1 (de) * | 1984-10-10 | 1986-04-17 | Mack Chem Pharm | Stabilisierte injektionsloesungen von piroxicam |
IT1207994B (it) * | 1986-01-03 | 1989-06-01 | Therapicon Srl | Sali idrosulubili di composti adattivita' antiinfiammatoria ed analgesica, loro preparazione ed utilizzo in composizioni farmaceutiche. |
IT1216686B (it) * | 1988-04-01 | 1990-03-08 | Chiesi Farma Spa | Formulazioni farmaceutiche acquose di piroxicam e procedimento per laloro preparazione. |
EP0418596A3 (en) * | 1989-09-21 | 1991-10-23 | American Cyanamid Company | Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form |
HU205550B (en) * | 1990-11-27 | 1992-05-28 | Egyt Gyogyszervegyeszeti Gyar | Process for producing pyroxycam solution of increased stability, free from effects damaging tussues |
US8178516B2 (en) * | 1992-06-30 | 2012-05-15 | Sylvan Labs, LLC | Compositions and method for treatment of chronic inflammatory diseases |
US5380934A (en) * | 1992-10-29 | 1995-01-10 | Kyowa Hakko Kogyo Co., Ltd. | Process for producing alanylgutamine |
US5700816A (en) * | 1995-06-12 | 1997-12-23 | Isakson; Peter C. | Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor |
DE69636413T2 (de) * | 1995-11-13 | 2007-03-29 | North West University | Verabreichungsmedium für analgetische, entzündungshemmende und antipyretische wirkstoffe und pharmazeutische zusammensetzungen enthaltend solches medium und wirkstoffe |
ES2175425T3 (es) * | 1996-06-20 | 2002-11-16 | Novartis Ag | Antibiotico micrococcina para la prevencion y tratamiento de la mastitis. |
JP2000516222A (ja) * | 1996-08-15 | 2000-12-05 | ロザン ファルマ ゲゼルシャフトミットベシュレンクテル ハフツング | 嚥下が容易な経口医薬組成物 |
US6071539A (en) * | 1996-09-20 | 2000-06-06 | Ethypharm, Sa | Effervescent granules and methods for their preparation |
US6090800A (en) * | 1997-05-06 | 2000-07-18 | Imarx Pharmaceutical Corp. | Lipid soluble steroid prodrugs |
WO1999009988A1 (en) * | 1997-08-27 | 1999-03-04 | Hexal Ag | New pharmaceutical compositions of meloxicam with improved solubility and bioavailability |
AU9062998A (en) * | 1997-09-11 | 1999-03-29 | Nycomed Danmark A/S | Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (nsaids) |
RS49982B (sr) * | 1997-09-17 | 2008-09-29 | Euro-Celtique S.A., | Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2 |
SE9703693D0 (sv) * | 1997-10-10 | 1997-10-10 | Astra Pharma Prod | Novel combination |
US6136804A (en) * | 1998-03-13 | 2000-10-24 | Merck & Co., Inc. | Combination therapy for treating, preventing, or reducing the risks associated with acute coronary ischemic syndrome and related conditions |
US6184220B1 (en) * | 1998-03-27 | 2001-02-06 | Boehringer Ingelheim Pharma Kg | Oral suspension of pharmaceutical substance |
EP0945134A1 (de) * | 1998-03-27 | 1999-09-29 | Boehringer Ingelheim Pharma KG | Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation |
EP1082966A4 (en) * | 1998-05-15 | 2004-07-21 | Wakamoto Pharma Co Ltd | ANTI-INFLAMMATORY EYE DROPS |
US6319519B2 (en) * | 1998-07-07 | 2001-11-20 | Norton Healthcare Ltd. | Anti-inflammatory pharmaceutical formulations |
DE19847968A1 (de) * | 1998-10-17 | 2000-04-20 | Boehringer Ingelheim Pharma | Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen |
US6180136B1 (en) * | 1998-11-10 | 2001-01-30 | Idexx Laboratories, Inc. | Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use |
US6183779B1 (en) * | 1999-03-22 | 2001-02-06 | Pharmascience Inc. | Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin |
US6166012A (en) * | 1999-07-30 | 2000-12-26 | Allergan Sales, Inc. | Antibiotic compositions and method for using same |
FR2798289B1 (fr) * | 1999-09-15 | 2004-12-31 | Cll Pharma | Formes galeniques a delitement rapide en bouche et leur procede de preparation |
AU1548001A (en) * | 1999-11-24 | 2001-06-04 | Wakamoto Pharmaceutical Co., Ltd. | Ophthalmic aqueous preparation |
AU2001257511A1 (en) * | 2000-05-03 | 2001-11-12 | Joe D'silva | Process and device for producing liquid dosage formulations |
WO2001087343A2 (en) * | 2000-05-15 | 2001-11-22 | Merck Frosst Canada & Co. | Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor |
AU2001264729A1 (en) * | 2000-05-22 | 2001-12-03 | Nitromed, Inc. | Thromboxane inhibitors, compositions and methods of use related applications |
DE10030345A1 (de) * | 2000-06-20 | 2002-01-10 | Boehringer Ingelheim Vetmed | Hochkonzentrierte stabile Meloxicamlösungen |
US20020035107A1 (en) * | 2000-06-20 | 2002-03-21 | Stefan Henke | Highly concentrated stable meloxicam solutions |
DE10032132A1 (de) * | 2000-07-01 | 2002-01-17 | Lohmann Therapie Syst Lts | Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung |
US6375982B1 (en) * | 2000-07-05 | 2002-04-23 | Capricorn Pharma, Inc. | Rapid-melt semi-solid compositions, methods of making same and method of using same |
JP2004503588A (ja) * | 2000-07-13 | 2004-02-05 | ファルマシア・コーポレーション | 全身性疼痛および頭痛に対する選択的シクロオキシゲナーゼ−2阻害薬および血管調節化合物 |
ES2223209B1 (es) * | 2001-12-11 | 2005-10-01 | Esteve Quimica, S.A. | Nuevas formas cristalinas del meloxicam y procedimientos para su preparacion e interconversion. |
US20040204413A1 (en) * | 2001-01-26 | 2004-10-14 | Joaquina Faour | Pharmaceutical compositions containing a COX-II inhibitor and a muscle relaxant |
AU2002306868A1 (en) * | 2001-03-28 | 2002-10-15 | Pharmacia Corporation | Therapeutic combinations for cardiovascular and inflammatory indications |
US20020187187A1 (en) * | 2001-04-21 | 2002-12-12 | Toshimitsu Ohki | Fast disintegrating meloxicam tablet |
US20040253312A1 (en) * | 2001-09-28 | 2004-12-16 | Sowden Harry S. | Immediate release dosage form comprising shell having openings therein |
AU2002340063B2 (en) * | 2001-09-28 | 2007-05-10 | Brigham Young University | Novel cyclooxygenase variants and methods of use |
DE10161077A1 (de) * | 2001-12-12 | 2003-06-18 | Boehringer Ingelheim Vetmed | Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion |
US20040001883A1 (en) * | 2002-03-30 | 2004-01-01 | Boehringer Ingelheim International Gmbh | Meloxicam suppositories |
US20040024042A1 (en) * | 2002-04-02 | 2004-02-05 | Vanderbilt University | COX2 inhibition in the prevention and treatment of autosomal dominant polycystic kidney disease |
DE10223013A1 (de) * | 2002-05-22 | 2003-12-04 | Boehringer Ingelheim Int | Verwendung von Meloxicam für die Linderung von Organverletzungen während Organoperation oder -transplantation |
US20040037869A1 (en) * | 2002-08-16 | 2004-02-26 | Douglas Cleverly | Non-animal product containing veterinary formulations |
UY27984A1 (es) * | 2002-09-17 | 2004-04-30 | Nippon Boehringer Ingelheim Co | Composicion farmaceutica para el suministro por via topica de meloxicam |
US20040171611A1 (en) * | 2002-09-30 | 2004-09-02 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Crystalline acetic acid solvate of meloxicam |
US8992980B2 (en) * | 2002-10-25 | 2015-03-31 | Boehringer Ingelheim Vetmedica Gmbh | Water-soluble meloxicam granules |
DE10250081A1 (de) * | 2002-10-25 | 2004-05-13 | Boehringer Ingelheim Vetmedica Gmbh | Wasserlösliche Meloxicam Granulate |
CA2413705A1 (en) * | 2002-12-06 | 2004-06-06 | Raul Altman | Use of meloxicam in combination with an antiplatelet agent for treatment of acute coronary syndrome and related conditions |
US20050197332A1 (en) * | 2002-12-10 | 2005-09-08 | Boehringer Ingelheim International | Use of meloxicam in combination with an antiplatelet agent for treatment of acute coronary syndrome and related conditions |
US8512727B2 (en) * | 2003-03-03 | 2013-08-20 | Alkermes Pharma Ireland Limited | Nanoparticulate meloxicam formulations |
US20040204472A1 (en) * | 2003-03-04 | 2004-10-14 | Pharmacia Corporation | Treatment and prevention of obesity with COX-2 inhibitors alone or in combination with weight-loss agents |
US20040214753A1 (en) * | 2003-03-20 | 2004-10-28 | Britten Nancy Jean | Dispersible pharmaceutical composition for treatment of mastitis and otic disorders |
US20040198826A1 (en) * | 2003-04-07 | 2004-10-07 | Boehringer Ingelheim International Gmbh | Pharmaceutical combination for treating benign prostatic hyperplasia or for treating abacterial prostatitis |
US20050038018A1 (en) * | 2003-07-09 | 2005-02-17 | Boehringer Ingelheim International Gmbh | Meloxicam compositions |
US20050147664A1 (en) * | 2003-11-13 | 2005-07-07 | Elan Pharma International Ltd. | Compositions comprising antibodies and methods of using the same for targeting nanoparticulate active agent delivery |
EP1568369A1 (en) * | 2004-02-23 | 2005-08-31 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the treatment of respiratory diseases in pigs |
DE102004021281A1 (de) * | 2004-04-29 | 2005-11-24 | Boehringer Ingelheim Vetmedica Gmbh | Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin |
DE102004025324A1 (de) * | 2004-05-19 | 2005-12-08 | Boehringer Ingelheim Vetmedica Gmbh | Flüssige Zubereitung für die Veterinärmedizin, Verfahren zu deren Herstellung und deren Verwendung |
CA2602374A1 (en) * | 2005-03-23 | 2006-09-28 | Boehringer Ingelheim International Gmbh | Composition comprising a combined thromboxane receptor antagonist and thromboxane synthase inhibitor and a cox-2 inhibitor |
BRPI0617208A2 (pt) * | 2005-09-30 | 2011-07-19 | Boehringer Ingelheim Vetmed | preparação farmacêutica contendo meloxicam |
WO2011046853A1 (en) * | 2009-10-12 | 2011-04-21 | Boehringer Ingelheim Vetmedica Gmbh | Containers for compositions comprising meloxicam |
US9795568B2 (en) * | 2010-05-05 | 2017-10-24 | Boehringer Ingelheim Vetmedica Gmbh | Low concentration meloxicam tablets |
-
2004
- 2004-06-23 DE DE102004030409A patent/DE102004030409A1/de not_active Withdrawn
-
2005
- 2005-05-12 US US11/127,990 patent/US20050288280A1/en not_active Abandoned
- 2005-06-11 KR KR1020077001669A patent/KR20070036146A/ko not_active Application Discontinuation
- 2005-06-11 SG SG200907675-3A patent/SG157402A1/en unknown
- 2005-06-11 CA CA002570596A patent/CA2570596A1/en not_active Abandoned
- 2005-06-11 WO PCT/EP2005/006276 patent/WO2006000306A1/en active Application Filing
- 2005-06-11 AU AU2005256377A patent/AU2005256377B2/en not_active Withdrawn - After Issue
- 2005-06-11 BR BRPI0512311-9A patent/BRPI0512311A/pt not_active IP Right Cessation
- 2005-06-11 CN CNA2005800209923A patent/CN1972690A/zh active Pending
- 2005-06-11 EP EP05763650A patent/EP1761269A1/en not_active Withdrawn
- 2005-06-11 NZ NZ552718A patent/NZ552718A/en not_active IP Right Cessation
- 2005-06-11 MX MXPA06014599A patent/MXPA06014599A/es not_active Application Discontinuation
- 2005-06-11 JP JP2007517132A patent/JP2008503509A/ja active Pending
- 2005-06-22 AR ARP050102566A patent/AR049934A1/es active Pending
Also Published As
Publication number | Publication date |
---|---|
KR20070036146A (ko) | 2007-04-02 |
SG157402A1 (en) | 2009-12-29 |
AU2005256377B2 (en) | 2011-04-07 |
WO2006000306A1 (en) | 2006-01-05 |
MXPA06014599A (es) | 2007-06-05 |
NZ552718A (en) | 2010-06-25 |
CA2570596A1 (en) | 2006-01-05 |
BRPI0512311A (pt) | 2008-02-26 |
JP2008503509A (ja) | 2008-02-07 |
CN1972690A (zh) | 2007-05-30 |
DE102004030409A1 (de) | 2006-01-26 |
EP1761269A1 (en) | 2007-03-14 |
AU2005256377A1 (en) | 2006-01-05 |
US20050288280A1 (en) | 2005-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR049934A1 (es) | Nuevo uso de meloxicam en medicina veterinaria | |
AR048718A1 (es) | Uso de formulaciones de meloxicam en medicina veterinaria | |
CR10167A (es) | "uso de derivados de sulfamida heterociclica benzo-fusionada para el tratamiento de dolor" | |
AR063201A1 (es) | Composiciones farmaceuticas de ropinirol y metodos de uso de las mismas | |
CO2021000174A2 (es) | Composiciones tópicas para el alivio del dolor | |
MX2007005570A (es) | Metodos y composiciones que usan compuestos inmunomoduladores para el tratamiento y manejo de padecimientos parasiticos. | |
EA201070940A1 (ru) | Жидкая лекарственная форма фсг | |
WO2007072503A3 (en) | Combinations for managing inflammation and associated disorders | |
WO2008027350A3 (en) | Acetaminophen pharmaceutical compositions | |
CL2012002126A1 (es) | Composicion farmaceutica topica que comprende 1`-{[5-(trifluorometil)furan-2-il]metil}espiro[furo[2,3-f][1,3]benzodioxol-7,3`-indol]-2`(1`h)-ona; y uso para tratar, una enfermedad o condicion tal como dolor neuropatico, dolor quirurgico, dolor por trauma, dolor de cabeza cronico, entre otras. | |
EA200700214A1 (ru) | Мемантин в качестве дополнительной терапии к атипичным антипсихотическим средствам у больных шизофренией | |
WO2006081127A3 (en) | Compositions and therapeutic methods utilizing a combination of a 5-ht1f inhibitor and an nsaid | |
AR040248A1 (es) | Farmaco para el tratamiento de la vejiga hiperactiva | |
BRPI0912112B8 (pt) | composição farmacêutica compreendendo composto tendo atividade antagonística em receptor de adenosina a2a útil em suprimir tolerância analgésica | |
AR052322A1 (es) | Compuestos de n-benzoil-estaurosporina, procesos para su preparacion y composicion farmaceutica | |
MX2009011900A (es) | Curacion de herida diabetica. | |
AR044350A1 (es) | Manguito y parche analgesico microencapsulado de uso topico para el tratamiento del dolor | |
BRPI0518062A (pt) | uso de um modulador de pde4, ou um sal, solvato, ou estereoisÈmero farmaceuticamente aceitável do mesmo, e, composição farmacêutica | |
WO2006088945A3 (en) | Granulysin peptides and methods of use thereof | |
AR056517A1 (es) | Composiciones y metodos farmaceuticos utilizando temozolomida y un inhibidor de la proteina quinasa | |
AR048806A1 (es) | Uso de cariofilenos en la elaboracion de medicamentos y tratamiento de afecciones corporales de inflamacion y dolor inflamatorio | |
ECSP11010941A (es) | Composición farmacéutica para el uso en el tratamiento de infecciones de transmisión sexual | |
AR061046A1 (es) | Mirtazapina para el tratamiento del dolor neuropatico | |
AR047684A1 (es) | Composiciones de drogas descongestivas o anti-histaminicas y anti-inflamatorios no esteroides | |
AR122320A1 (es) | Composiciones tópicas para el alivio del dolor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |